Physician profile
Dali Chen
NPI 1801890538
$1,862.56
in general payments reported to CMS, 2019-2025
11 companies · $467 in 2025
The $467 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $623 · 2020: $122 · 2022: $87.48 · 2023: $343 · 2024: $220 · 2025: $467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,030.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,030.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $433.30 | 2019-2025 | Dexcom G6 Transmitter |
| Tandem Diabetes Care, INC. | $308.61 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Amgen INC. | $233.46 | 2019 | |
| Medtronic, INC. | $216.28 | 2023-2025 | Minimed 780g |
| Abbott Laboratories | $152.12 | 2024 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2025 | Jardiance |
| Novo Nordisk INC | $124.73 | 2019 | |
| Beta Bionics, INC. | $100.74 | 2023 | Ilet Bionic Pancreas |
| Insulet Corporation | $87.48 | 2022 | |
| Companion Medical, INC. | $47.51 | 2019 | |
| Sequel Med Tech, LLC | $33.33 | 2025 | Twiist |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dali Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.